Article
A population-based case-control study of the CYP2D6 and GSTT1 polymorphisms and malignant brain tumors.
Pharmacogenetics - 1 Dec 1997
Kelsey K T, Wrensch M, Zuo Z F, Miike R, Wiencke J K
Abstract excerpt
Previous studies of associations of metabolic polymorphisms with the occurrence of malignant brain tumors have suggested that there is a significantly increased risk of development of adult gliomas in individuals who carry a poor metabolizer CYP2D6 variant allele and the GSTT1 null genotype. To investigate this further, a population-based case control study of adult glioma in the San Francisco Bay area was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
